MINNEAPOLIS--(BUSINESS WIRE)--The Dolan Company (NYSE: DM), a leading provider of professional services and business information to the legal, financial and real estate sectors in the United States, today announced that it has priced an underwritten public offering of its 8.5% Series B Cumulative Preferred Stock (the “Series B Preferred Stock”) at a public offering price of $23.00 per share. Gross proceeds to the company are expected to be approximately $16.1 million. The company plans to use the net proceeds from the offering to repay borrowings outstanding under its credit facility. MLV & Co. LLC is acting as sole book-running manager for the offering, and Dougherty & Company and Northland Capital Markets are acting as co-managers for the offering.
Closing of the offering is scheduled for January 31, 2013, subject to customary closing conditions. The company is filing an application to list the Series B Preferred Stock on the New York Stock Exchange under the symbol “DMPrB.”
The shares will be issued pursuant to a registration statement that has been declared effective by the Securities and Exchange Commission (the “SEC”). A final prospectus supplement relating to the offering will be filed with the SEC. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.
The offering of these securities will be made only by means of a prospectus and accompanying prospectus supplement. When available, copies of the prospectus and final prospectus supplement relating to these securities may be obtained by contacting MLV & Co. LLC, 1251 Avenue of the Americas, New York, New York 10020, Attention: Randy Billhardt, e-mail: RBillhardt@mlvco.com, telephone: 212-542-5882.
The Dolan Company is a leading provider of professional services and business information to the legal, financial and real estate sectors. Its Professional Services Division provides specialized outsourced services to the legal profession through its subsidiaries, NDeX, DiscoverReady and Counsel Press. NDeX is a leading provider of mortgage default processing services in the United States. DiscoverReady provides outsourced discovery management and document review services to major companies and law firms. Counsel Press is the nation's largest provider of appellate services to the legal community. The company's Business Information Division publishes business journals, court and commercial media and other highly focused information products and services, operates web sites and produces events for targeted legal and professional audiences in each of the 19 geographic markets that it serves across the United States.
“Northland Capital Markets” is the trade name for certain capital markets and investment banking services of Northland Securities, Inc., member FINRA/SIPC.
Statement Regarding Forward Looking Information
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not historical or current facts are forward-looking statements. Such forward-looking statements include statements related to the company’s offering of the Series B Preferred Stock and the planned use of proceeds. Forward-looking statements are subject to risks, uncertainties and other factors that are difficult to predict and many of which are beyond management’s control. These risks, uncertainties and other factors include, but are not limited to, those described under “Risk Factors” in Item 1A of our annual report on Form 10-K for the year ended December 31, 2011, filed with the SEC on March 9, 2012, and those described in filings made with the SEC in connection with the offering of the Series B Preferred Stock. We undertake no obligation to update any forward-looking statements in light of new information or future events.